ASCO 6/2011Chicago report-abstracts available for those who can’t wait
- This topic has 6 replies, 4 voices, and was last updated 13 years, 5 months ago by
.
-
Posts
-
Following Percy’s search instructions –
1st page, 10 abstracts –
http://abstractsearch.asco.org/cgi-bin/ts.pl?index=442064&query=cholangiocarcinoma&opt=any
2nd page, 4 abstracts –
Thanks again Percy!
Hi PCL1029 !
I am the one taking Anvirzel. Thank you VERY much for taking the time to sit in for the discussion at Chicago. It’s disappointing that Drs. Khan and Newman weren’t there.
I’m sorry that I did not have a chance to meet you and the other people there.
I had planned /looked forward for a long time to attend, even bought the airline ticket, but at the last minute something came up. I regret very much not being there.
Anyway–if this is of interest to anyone, I am s/p 40% left hepatic resection 1/19/10 and I have being taking Anvirzel 0.5mg, SL, q 5 hr. /day( except while sleeping ) since last July.
I have had NO side effects at all, all labs WNL, CT SCAN with contrast every 4 months indicate ‘Stable’. I intend to keep taking it until further notice.
I am only too glad that you were there, but do wish that I had been able to attend.
Thank you very much for sharing your knowledge and for the way that you explain things.
Lesley, aka Snezzie.Even during 6 months ( 8 cycles ) of Gem/Xeloda.
Dear Percy, thank you so much for attending the conference and the wonderful way you present things here to our CC Board. We expect nothing less than another 15 years at the very least for you to spend with all of us! I remember when Teddy and I attended a convention here and it really only took 5 minutes from the parking lot to the Convention Center, sorry about that but I am sure it was all so very exciting! I can’t wait for some day to come when we can all meet! Take care and feel good!
Hi,
Thanks Gavin.I was instructed to go to” Experimental Therapeutic” oral session to listen to Dr.Khan and Newman about PBI-05204 for a member of us who is currently taking that experimental drug call Anvirzel. Both of the doctors did not show up for discussion.
However, another researcher did mention about PBI-05204 when she compared
it to another compound about the side effects like proteinuria ,fatigue ,diarrhea
,constipation and abdominal pain , just to name a few.I will keep all of you informed as my energy level comes back a bit more and after I review my notes .
McCormick Place in Chicago is the largest conventional place in the world.
It can easily take 30 min to walk from the west to east end.(not counting the distance from the garage where you have to park.)As a patient,I am interested in the near term solution first,what information are available to help me NOW-both in treatments plans and current resources.
I found them surprisingly in the Pharmaceutical companies and in the poster sessions.
Second,I am looking down the road(1-5 years) what will be my options,(that is,if my current treatment plans not working ,what should I do to maximize my chance of survival; and
third what is the future in so call “targeted drug therapy” researches that can help future new CC patients.
I can give you a very simple answer for the last question I raised. the answer is- it will be a long time (10-15 years) before all those experiments which are promising-that is the chemicals showing SOME responses to solid tumors-and CC is one of them- ( they are now testing in mice only in the lab);these are so called “The next-generation therapeutic target and drugs”; an oral session that I attended and I will discuss it after I read my notes.
For the first and 2nd questions I raised,I did find some interesting options or other means to increase patient chances of survival and to better serve” patient specific “needs.
and I will do this first as soon as after I reorganize my materials.
Thanks for the chance to do this ;and next time ,I will know where to look first for the most up-to-date info. for all of us.( I will pay much more attention on current available treatments rather than looking for a magic bullet in the experimental therapeutic elements.
But the trends for all those big and small pharmaceutical companies like Elilly,Merck,Genentech, Sanfofi;Daiichi-Sankyo and Norvartis are toward molecularly targeted drugs research or developing bio-markers for prognostic or predictive purposes.(as the evidence shows here at the ASCO conference, almost 100% in their booths showing videos and printed materials on these two subjects besides advertising their current products like Avastin,Gemzar,Xyloda and Erbitux etc.)
god bless.God bless
Hi,
http://chicago2011.asco.org/Abstracts.aspx
on the left hand side ,click Abstracts.
then scroll down on the right side under highlight(the red box),click abstracts
put in cholangiocarcinoma in the search field; 14 related CC abstracts will show up.some are useful(abstract 4101*,e14667,*4116,)*=related to disease markers.
some may be of value(abstract e14626
some are hopeful for potential new treatment.(3007;e19581;3091
some are harmful(e14593;e14658
this is may be helpful for caretakers(e19689)
I will try to report the rest that are related to cc but not on the ASCO web sites yet.
God bless.
- The forum ‘General Discussion’ is closed to new topics and replies.